Resmed
ResMed Inc., a leading player in the sleep and respiratory care industry, is headquartered in the United States, with significant operations across Europe, Asia, and Australia. Founded in 1989, ResMed has consistently innovated in the development of cloud-connected devices and software solutions that enhance patient care and improve quality of life for those with sleep apnoea and chronic obstructive pulmonary disease (COPD). The company’s core offerings include advanced continuous positive airway pressure (CPAP) devices, portable oxygen concentrators, and digital health solutions, all designed to provide seamless integration and user-friendly experiences. ResMed's commitment to research and development has positioned it as a market leader, recognised for its pioneering technologies and significant contributions to the field of sleep medicine. With a strong focus on improving patient outcomes, ResMed continues to set benchmarks in the healthcare industry.
DitchCarbon Score
How does Resmed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Resmed's score of 40 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Resmed's reported carbon emissions
As of 2023, ResMed's total carbon emissions amounted to approximately 28,391,000 kg CO2e, with Scope 1 emissions at about 4,453,000 kg CO2e and Scope 2 emissions at around 23,939,000 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, having set a long-term target to achieve net-zero emissions across all scopes by 2050. This commitment aligns with the Science Based Targets initiative (SBTi), which ResMed joined in February 2023, indicating its dedication to sustainable practices in the healthcare equipment and supplies sector. In recent years, ResMed's emissions have fluctuated, with a total of approximately 25,059,000 kg CO2e reported in 2024, down from about 28,658,000 kg CO2e in 2022. The company has also reported significant Scope 3 emissions, which reached approximately 35,383,000 kg CO2e in 2021, highlighting the importance of addressing emissions beyond direct operations. ResMed's proactive approach to climate commitments reflects its recognition of the urgent need for sustainability in the healthcare industry, aiming to contribute positively to global climate goals while continuing to innovate in its product offerings.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Resmed is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
